BiomarkersHumansPreprint281,729 participantsCross-sectional study

Routine data helped target frailty checks in chronic disease

In the model’s validation sample, screening the highest-risk 20% identified 55.6% of frailty cases, a 2.78-fold improvement over random screening.

medRxiv

An observational prediction study used UK Biobank data from 281,729 adults with at least one chronic condition, whose mean age was 57.9. Researchers combined 12 routine, low-cost clinical measures in a model to predict frailty, a state of reduced resilience to illness or injury. Overall, 5.8% of participants were frail.

The team developed the model using 187,819 participants and tested it in a separate group of 93,910. Selecting the highest-risk 20% for screening identified 55.6% of frailty cases in this validation group. Screening performance remained consistent across 3,284 modelling settings. Frailty remained associated with poor outcomes across predicted risk levels.

Why it matters

Frailty assessment can guide care for adults with chronic diseases as they age. The study addressed how to prioritise these assessments when screening everyone is resource-intensive.

Caveats

This observational prediction study evaluated screening in existing data, not its use in routine clinical care. The paper is a preprint and has not yet been peer-reviewed.

The paper

Use of routine clinical data in adults with chronic diseases for identifying risk of frailty: results from the UK Biobank study

B. Landre, G. C. Silva, A. Fayosse,
Show 4 more authorsI. Meneghel Danilevicz, W. Lieb, S. Sabia, A. Singh Manoux,
P. Sturmer

Kiel University

medRxiv · 7 Oct 2026 · CC BY-NC-ND · Preprint, not peer-reviewed

doi.org/10.64898/2026.10.05.26364730